Biogen's Alzheimer's drug lowers toxic protein, but results were mixed - Reuters
Biogen's Alzheimer's drug lowers toxic protein, but results were mixed Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxQZjkxUXJSY1ZCREl0RGZWaDJ0OUhoU1J5d3I3ZFpXQURiTUYtQnFEWVkweHJZMmVYU1R1dVBUY01FQ2U3SVlKZEVyQnBFS2ZrNVcwR0lKUFFoU0FyTDEtU01zTHNKM01WdHBMTnlpNDZkVXdIQVM2TUtnaUVqaU1kSVV2Z3pqSFZLMm9Ydmh1TmtJRE5ORnJVSnZkQjhHeFJkZWEwYTlBd0U4UlFYN3psbThxaXJ3VmxsVVB5QjhuQ0JzQXI3UDdmdGZPNDRGSVFh?oc=5" target="_blank">Biogen's Alzheimer's drug lowers toxic protein, but results were mixed</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance - Reuters
Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance Reuters
August 24, 2026 at 05:39 PMGSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
August 24, 2026 at 07:11 AMAstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial - Reuters
AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial Reuters
August 27, 2026 at 06:10 AMBristol Myers ends blood cancer drug deal with cell therapy maker Cellares - Reuters
Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares Reuters
August 25, 2026 at 06:00 PMBioNTech halts mRNA colorectal cancer vaccine trial after safety review - Reuters
BioNTech halts mRNA colorectal cancer vaccine trial after safety review Reuters
August 28, 2026 at 05:12 PMUS FDA expands approval for J&J's drug for rare blood disorder - Reuters
US FDA expands approval for J&J's drug for rare blood disorder Reuters
August 24, 2026 at 10:49 PM